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KATZ, R. J., K. A. ROTH AND K. SCHMALTZ. Amphetamine and tranylcypromine in an animal model of depression: 
Pharmacological specificity of the reversal effect. NEUROSCI. BIOBEHAV. REV. 5(2) 259-264, 1981 .--Amphetamine 
and tranylcypromine are structurally related chemical isomers with pharmacologically distinctive activity prof'des. Since 
they are equimolar and structurally similar they may be used to assess the pharmacological specificity of a proposed animal 
model of depression. Adult male Sprague-Dawley rats were exposed to a chronic stress regimen or remained undisturbed. 
They were then acutely stressed with white noise. The monoamine oxidase inhibitor tranyicypromine was effective in 
restoring otherwise reduced stress elicited open field activity in chronically stressed rats. Amphetamine did not resemble 
tranyicypromine or other antidepressants, and produced a variety of effects at least some of which indicated a potential 
increase rather than reduction in depression consequent to chronic administration. 
Activity Ambulation Amphetamine Animal model of depression Antidepressant Defecation 
Monoamine oxidase inhibitor Open field Stress Tranylcypromine 
AMPHETAMINES and related sympathomimetic drugs are 
troublesome for many antidepressant screening techniques. 
While they are not routinely useful in the clinical therapy of  
depression and indeed may exacerbate a preexisting mood 
disorder  they yield false positives on laboratory tests such as 
synergism tests,  muricide, and other related procedures [6, 
9, 10]. Heretofore amphetamines have not been examined in 
the proposed animal model of  depression. Such a test is 
clearly desirable as an indicator of  screening specificity and 
as a means of  comparing the open field/stress procedure with 
other tests. 
The present experiment examined the efficacy of  
d-amphetamine and compared it with tranylcypromine. 
These drugs are both modified phenylethylamines, each con- 
taining one methyl group in a similar position. Being struc- 
tural isomers of  each other, they therefore are equimolar. 
Despite chemical similarities however,  differences in the 
methyl group render the compounds quite dissimilar at a 
pharmacological level. Amphetamine is a highly addictive 
psychostimulant with weak monoamine oxidase (MAO) in- 
hibitory properties.  Tranylcypromine is a potent and clini- 
cally useful MAO inhibitor but is only mildly stimulating and 
weakly addictive [2, 3, 5]. 
It might be predicted that if the present model is accurate 
and specific then only tranylcypromine will resemble 
antidepressants in its behavioral profile. Amphetamine 
should appear to be qualitatively different, and should not 
reverse the effects of  chronic stress although predictions 
past  this are less certain. 
METHOD 
Subjects 
Adult male Sprague-Dawley rats (n=96) each seventy 
days at the start of  testing were double housed with food, 
water and lighting as previously described [7,12]. Twenty- 
four rats were used solely for hormonal assays while the 
remainder were used for behavioral and subsequent 
endocrine study. 
Apparatus and Behavioral Procedure 
All materials and methods are identical to those of  two 
previous reports. The present behavioral test involved a nine 
minute exposure to the open field. The chronic stress regi- 
men was similar to that utilized previously and consisted of  
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2 Food deprivation (40 hr) 
3 Cold swim 
4 Water deprivation (40 hr) 
5 
6 Heat stress 
7 Shaker stress 
8 Light/dark cycle reversal 
9 Cold swim 
l0 Shock 
11 Switch cage mates 
12 Heat and switch cage mates 
13 Remove food and increase housing density (4/cage) 
14 
15 Light/dark cycle reversal 
16 Cold swim 
17 
18 Shock 
19 Water deprivation (40 hr) 
20 Shaker 
21 Test 
exposure to sixty minutes of  unpredictable shock (average 1 
mA, 1-10 sec duration; average 1 shock/minute (3 expo- 
sures); 40 hours food deprivation (2 times); cold swim at 
4.0°C for 5 minutes (3 exposures); 40 hours water  deprivation 
(2 times); 5 minutes exposure to heat stress at 40"C (2 times); 
30 minutes shaker stress (2 times); reversal of  day/night 
cycle (2 times). Stressors were delivered in a semirandom 
fashion every 1-2 days throughout the day/night cycle from 
08:00 through 22:00 hr. Order of stress administration is pre- 
sented in Table I. 
Behavioral testing involved either of  two procedures.  
Control (Basal) subjects were tested without further manipu- 
lations. Experimental subjects were exposed to an acute 
stress of  1 hr duration. Acute stress involved the 95 dB 
noise-light procedure described previously [6,11]. Testing 
procedures and behavioral measures were equivalent to 
previous descriptions with one exception. In contrast to 
previous tests the present test was conducted between 0:800 
and 13:00 hr, i.e., during the normal light period. The follow- 
ing experimental and control groups served as the basis for 
statistical comparisons: (1) Basal control conditions (vehicle 
injection, no history of  chronic stress prior to testing); (2) 
Chronically stressed control conditions (vehicle injection 
during chronic stress procedure); (3) Amphetamine groups 
(all chronically stressed); (4) Tranylcypromine groups (all 
chronically stressed). In addition to the above four (condi- 
tions) by two (basal vs acute stress) factorial design involv- 
ing behavioral tests, separate groups of  rats (n=32) were 
sacrificed without exposure to the open field to provide basal 
indicators of  endocrine status unconfounded by behavioral 
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FIG. l. Mean motor activity (outside squares/3 min)+standard error 
for rats tested in a n open field. B=basal; A=acute (95 dB white 
noise) stressed; C=chronically stressed; NaCl=vehicle injected; 
Amph=amphetamine injected (3 mg/kg/day); Tran=tranylcyp- 
romine injected (3 mg/kg/day). Course of injections was 3 weeks. In 
all cases the leftmost of the 2 adjacent columns represents basal 
open field motor activity while the right column shows rats acutely 
stressed prior to testing in an open field. 
Drugs 
Sulphate salts of  amphetamine and tranylcypromine were 
prepared as 3 mg/ml solutions in 0.9% sodium chloride vehi- 
cle solution and injected intraperitoneally 1 ml/kg/day for the 
course of  testing (3 weeks). Drugs were discontinued 40 hr 
prior to the initiation of  behavioral testing. 
Statistical analysis utilized the univariate analysis of  vari- 
ance model as previously described [7,12]. Post hoc com- 
parisons across groups utilized Sheff~ allowances. 
RESULTS 
Stress produced a behavioral activation in the open field 
upon several dimensions. A history of  chronic stress reduced 
the normally occurring activation. Treatment with am- 
phetamines failed to reverse this relative depression, how- 
ever tranylcypromine was effective on a number of  measures 
in this regard. 
The results suggest the model can accurately discriminate 
a psychostimulant from an antidepressant,  even if the com- 
pounds are structurally quite similar. Specific behavioral 
categories are discussed below, and presented in Figs. 1-6. 
Activity (Outside Squares Minutes 0-3; Fig. 1 
Activity was characterized by significant mean differ- 
ences across cells, F(7,56)=3.1, p<0.01.  The significant 
(F=8.4,  p<0.001;  a probability of <0.05 is used as a criterion 
for post hoc statistical reliability for all comparisons unless 
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FIG. 2. Mean motor activity (center field penetration) + standard 
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FIG. 3. Mean rearing activity in an open field + standard error. See 
Fig. 1 for a complete explanation of figure legends. 
stated otherwise) elevation in activity produced by stress in 
control subjects is of  interest, and suggests the acute stress 
procedure was effective. This was abolished by chronic 
stress pretreatment (F=  1.6; n.s.) and was partially but not 
significantly restored by amphetamine (F= 1.7; n.s.). Due to 
an elevated baseline this was also only partially restored in 
the tranylcypromine group in comparison with its own 
chronically stressed control group ( F = l . 7 ;  n.s.). In partial 
support of  the experimental hypothesis however it may be 
noted that the tranylcypromine group given stress is not dif- 
ferent from the basal control group given stress (F=0.4;  n.s.) 
while other groups were significantly less. By a similar 
analysis the corresponding amphetamine group is signifi- 
cantly lower than the basally stressed group (F=4.5).  Based 
upon percentage response above baseline, acute stress in- 
creased responding 75, 42, 75 and 55%, respectively, in 
otherwise basal, chronically stressed, amphetamine treated 
and tranylcypromine treated rats. This apparent discrepancy 
will be commented on subsequently. Some albeit not fully 
conclusive evidence of  recovery is provided by the above 
findings. While the results are consistent with the hypoth- 
esized recovery,  differences in baselines must be taken into 
consideration. 
Center Field Penetration (Fig. 2) 
A significant effect across cells was present in the inside 
squares analysis, F(7,56)=24.2. The stress induced elevation 
was significant for basal groups (F=2.9) but not for any of  
the chronically stressed vehicle or  drugs groups (F=0.4,  0.2, 
0.2; n.s.) respectively,  for vehicle, amphetamine and tranyl- 
cypromine compared with their respective controls. 
Rearing (Fig. 3) 


























FIG. 4. Mean open field activity (latency to initially leave home 
square) plus standard error. Latencies are presented as seconds, 
figure legends are in Fig. 1. 
cally reliable manner (F=0.9;  p - 0 . 5 )  thus no funber  analysis 
was possible. 
Motor Latency (Fig. 4) 
An overall effect of  groups was present (F=2.8)  and this 
involved stress induced facilitation of initial motor activity 
for the basal group ( F - 5 . 2 ;  df  as above) and the tranylcyp- 
romine group (F=3.2).  This was absent for the chronically 
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FIG. 5. Mean open field defecation + standard error. Data represent 
bolus counts at the close of nine minutes of open field exposure. 
Figure legend presented in Fig. 1. 
stressed (F=I .1 ;  n.s.) and amphetamine treated (F=0.7) 
groups. Thus the latency measure successfully discriminated 
the 2 drugs. 
Defecation Score 1 (bolus count; Fig. 5) 
Defecation was reliably different across groups, 
F(7,56)=9.7, p<0.0001. This was due to a statistically reli- 
able reduction in scores of  the acutely stressed control rats 
(F=4.2).  This effect was also present in the vehicle treated 
(F=9.6) and tranylcypromine (F=31.2) groups but not in the 
amphetamine (F=  1.6; n.s.) group. 
Defecation Score 2 (Latency; Fig. 6) 
An overall effect of  groups was present,  F(7,56)=4.1, 
p <0.001, and was based upon stress induced elevated laten- 
cies in the basal control group (F=7.8)  and tranylcypromine 
groups (F=7.0).  Neither the vehicle treated chronically 
stressed rats (F=0.01; n.s.) nor the amphetamine rats (F=  1; 
n.s.) showed similar latency elevations with respect  to their 
controls. 
Plasma Corticosterone Measure (Fig. 7) 
An overall effect of  groups was present, F(11,85)=19.3, 
p<0.001.  Chronic stress elevated the resting plasma corti- 
costerone levels of  both behaviorally naive and open field 
tested rats (F=2.9,  4.6). The acute stress procedure 
produced a three fold rise in corticosterone in comparison to 
unstressed controls (F=6.9).  In addition open field testing 
was stressful for basal animals (F=  12.2). Both &'nphetamine 
and tranyleypromine significantly elevated resting levels of 
steroid in behaviorally naive subjects compared with their 
appropriate controls (F=5.8,  6.6) the intrinsic stimulant ef- 
fects of  both agents within the pituitary adrenal axis renders 
further comparisons difficult. Finally, neither drug treatment 
reduced the chronic stress induced steroid elevation, al- 
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FIG. 6. Mean defecation score (latency in sec) plus standard error. 
Figure legend is presented in Fig. 1. 
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FIG. 7. Plasma corticosterone values (mean value p.g/dl plus stand- 
ard error) left most columns were sacrificed without open field ex- 
posure. Middle columns are open field basal (not acutely stressed) 
groups while right most columns were exposed to the open field after 
1 hr of noise stress. Additional details of figure legend are in Fig. 1. 
though the finding of intrinsic endocrine stimulating activity 
for these agents prohibits additional comment.  
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FIG. 8. Mean ranks for total scores across categories for all groups 
(i.e., total activation score). Figure legend is presented in Fig. 1. 
Summary Measure (Fig. 8) 
A summary measure of  behavioral activity based upon 
relative ranks may add in further clarifying between groups 
differences. This measure was significantly, F(7,35)=17.8, 
and as may be seen this represents a stress induced overall 
activation which is specific for basal (F= 13.1) and tranylcyp- 
romine treated rats (F=8.6). Amphetamine treated and 
chronically stressed rats showed partial recovery to lower 
levels. Recovery was significantly lower than control 
(F=9.6, 9.9). 
DISCUSSION 
We have previously argued that the most informative and 
valid measures of  open field performance involve outside 
squares, defecation scores, and composite activity [1 I]. The 
locomotion measure provided qualified support for the hy- 
pothesis since only a clinically effective antidepressant re- 
versed the behavioral deficits produced by chronic stress. It 
must be kept in mind that on the basis of  percentage above 
baseline, a substantial increase was present for the am- 
phetamine group, and was due mainly to a greatly reduced 
baseline in comparison with other groups. This finding al- 
though not significant suggests stress had a weak effect in 
this group. It is known from the clinical literature that de- 
pressives may be able to respond weakly and inconsistently 
to their environment, but that the magnitude of  the response 
is also quite low. Beck describes a number of clinical cases 
characterized by " a  moderate to severe paralysis of  the will" 
[1]. Minor increases above a reduced baseline by am- 
phetamines may represent a similar process. At very least 
the present findings on locomotor activity argue for different 
patterns of  response for the two drugs, while the remainder 
of  the above measures provide yet stronger support for the 
hypothesis. As in previous reports [7, 11, 12] the rearing 
measure was not a particularly useful behavioral dis- 
criminator. 
Given the structural and biochemical similarities of  the 
two experimental compounds, the present findings are strik- 
ing. It must be emphasized these compounds are quite simi- 
lar, and thus amphetamines provide both a useful test and a 
stringent pharmacological control as well. 
As noted elsewhere, previous studies using other models 
have occasionally found amphetamine to yield a false posi- 
tive. A number of  reasons idiosyncratic to individual proce- 
dures may be involved in the production of  a false positive. 
Tests dependent upon noradrenergic disposition clearly will 
be sensitive to the releasing properties of  sympathomimetic 
drugs (5). A more general factor which may have contributed 
to the present differences is the extended course of  drug 
administration for all compounds. The effects of  drugs may 
vary with chronic administration. Most previous tests used 
acute administration but both clinical response and the pres- 
ent test require more prolonged drug exposure. It is not clear 
whether other tests would remain at their established levels 
of  specificity or improve with more chronic administration. 
The endocrine findings are consistent with the behavioral 
findings, but the intrinsic pituitary-adrenal stimulating activ- 
ity of  both experimental compounds prohibited an analysis 
of  antidepressant reversal of  corticosterone levels. 
The remainder of  this discussion will address the conse- 
quences of  procedural modifications unique to the present 
test. The present test schedule involved day-time rather than 
night-time assessment of  activity. It may be noted that the 
present scores, overall, reflected a lowering of activity 
across categories. The relative relationships of  these changes 
are not altered however. It should also be noted that the 
endocrine findings although partly consistent with the behav- 
ioral results and previous findings were confounded by fac- 
tors already mentioned. Clearly some drugs are by their na- 
ture active within the pituitary-adrenal axis and endocrine 
measures must be interpreted with initial consideration for 
the intrinsic effects of  drugs. 
In conclusion we have demonstrated a pharmacologically 
specific reversal of  depressed activity, and the relative inef- 
fectiveness of a psychostimulant in the present design. These 
results point to potential utility of the testing procedure. 
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